Works matching IS 10781552 AND DT 2017 AND VI 23 AND IP 3

Results: 11

Ibrutinib-associated tumor lysis syndrome in a patient with mantle cell lymphoma: A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 3, p. 235, doi. 10.1177/1078155216637218

By:

Kaur, Varinder;
Swami, Arjun

Publication type:

Article

Late-onset pericardial tamponade, bilateral pleural effusions and recurrent immune monoarthritis induced by ipilimumab use for metastatic melanoma.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 3, p. 231, doi. 10.1177/1078155216635853

By:

Dasanu, Constantin A.;
Jen, Tiffany;
Skulski, Ryszard

Publication type:

Article

Irinotecan-induced dysarthria: A case report and review of the literature.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 3, p. 226, doi. 10.1177/1078155216634181

By:

Ramirez, Krista G.;
Koch, Marla D.;
Edenfield, William J.

Publication type:

Article

Flipped script for gefitinib: A reapproved tyrosine kinase inhibitor for first-line treatment of epidermal growth factor receptor mutation positive metastatic nonsmall cell lung cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 3, p. 203, doi. 10.1177/1078155216634179

By:

Bogdanowicz, Brian S.;
Hoch, Matthew A.;
Hartranft, Megan E.

Publication type:

Article

Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: A case series.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 3, p. 220, doi. 10.1177/1078155216631407

By:

Campbell, Peter M.;
Ippoliti, Cindy;
Parmar, Sapna

Publication type:

Article

Pharmacists' roles in oncology pharmacy services: Results of a global survey.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 3, p. 185, doi. 10.1177/1078155216629827

By:

Holle, Lisa M.;
Harris, Christy S.;
Chan, Alexandre;
Fahrenbruch, Rebecca J.;
Labdi, Bonnie A.;
Mohs, Jocelyn E.;
Norris, Leann B.;
Perkins, Janelle;
Vela, Cory M.

Publication type:

Article

Healthcare resource use and costs associated with renal impairment in US patients with bone metastases from solid tumors.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 3, p. 195, doi. 10.1177/1078155216629826

By:

Qian, Yi;
Arellano, Jorge;
Bhowmik, Debajyoti;
Thomson, Erin;
Smith, David M.;
Hechmati, Guy;
Song, Xue

Publication type:

Article

Incidence of hypocalcemia in patients receiving denosumab for prevention of skeletal-related events in bone metastasis.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 3, p. 179, doi. 10.1177/1078155216628325

By:

Yerram, Prakirthi;
Kansagra, Shraddha;
Abdelghany, Osama

Publication type:

Article

Response of metastatic mucosal melanoma to immunotherapy: It can get worse before it gets better.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 3, p. 215, doi. 10.1177/1078155215627503

By:

Atrash, Shebli;
Makhoul, Issam;
Mizell, Jason S.;
Hutchins, Laura;
Mahmoud, Fade

Publication type:

Article

Effects of the leucovorin shortage: Pilot study investigating cost, efficacy, and toxicity comparison of low fixed-dose versus body surface area-adjusted leucovorin dosing in patients with resectable colon or metastatic colorectal cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 3, p. 163, doi. 10.1177/1078155215624262

By:

Shank, Brandon R.;
Seung, Amy H.;
Kinsman, Katharine;
Newman, Matthew J.;
Donehower, Ross C.;
Burton, Bradley

Publication type:

Article

High- versus low-dose leucovorin in the modified FOLFOX6 regimen for first-line treatment of metastatic colorectal cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 3, p. 173, doi. 10.1177/1078155215623085

By:

Reynolds, Jana;
Chamberland-Tremblay, April;
Herrington, Jon D.;
Munoz Maldonado, Yolanda;
Wong, Lucas

Publication type:

Article